Stay updated on Chemo +/- Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.

Latest updates to the Chemo +/- Nivolumab in NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5. This indicates a small software update to the page's underlying platform.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.6.4 is now displayed, replacing the previous Revision: v3.6.3. This represents a minor metadata update to the study page.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page. The update appears to be a minor backend or interface version bump without altering study details or eligibility.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page now shows revision v3.6.2, replacing the prior v3.6.0. This reflects a small maintenance/patch update to the site framework.SummaryDifference0.0%

- Check65 days agoChange DetectedNew help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Interventions header was reformatted. The page now notes that recruitment has ended and the revision is updated to v3.6.0.SummaryDifference0.5%

- Check72 days agoChange DetectedRevision tag updated to v3.5.5, replacing the previous v3.5.4.SummaryDifference0.0%

Stay in the know with updates to Chemo +/- Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.